Gary Chmielewski to Treatment Outcome
This is a "connection" page, showing publications Gary Chmielewski has written about Treatment Outcome.
Connection Strength
0.168
-
The safe transition from open to thoracoscopic lobectomy: a 5-year experience. Ann Thorac Surg. 2009 Jul; 88(1):216-25; discussion 225-6.
Score: 0.044
-
Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
Score: 0.020
-
Survival Benefit of Surgery after Chemoradiotherapy for Stage III (N0-2) Non-Small-Cell Lung Cancer Is Dependent on Pathologic Nodal Response. J Thorac Oncol. 2015 Oct; 10(10):1475-80.
Score: 0.017
-
Incidence of Esophageal Adenocarcinoma and Causes of Mortality After Radiofrequency Ablation of Barrett's Esophagus. Gastroenterology. 2015 Dec; 149(7):1752-1761.e1.
Score: 0.017
-
Effects of the Learning Curve on Efficacy of Radiofrequency Ablation for Barrett's Esophagus. Gastroenterology. 2015 Oct; 149(4):890-6.e2.
Score: 0.017
-
Development of a serum biomarker panel predicting recurrence in stage I non-small cell lung cancer patients. J Thorac Cardiovasc Surg. 2012 Dec; 144(6):1344-50; discussion 1350-1.
Score: 0.014
-
Prior fundoplication does not improve safety or efficacy outcomes of radiofrequency ablation: results from the U.S. RFA Registry. J Gastrointest Surg. 2013 Jan; 17(1):21-8; discussion p.28-9.
Score: 0.014
-
Benign post-esophagectomy gastrocardiac fistula. Interact Cardiovasc Thorac Surg. 2011 Oct; 13(4):447-9.
Score: 0.013
-
Radiographic and metabolic response rates following image-guided stereotactic radiotherapy for lung tumors. Radiother Oncol. 2011 Apr; 99(1):18-22.
Score: 0.013